Bristol-Myers Squibb
BMY
BMY
2,285 hedge funds and large institutions have $96B invested in Bristol-Myers Squibb in 2021 Q3 according to their latest regulatory filings, with 109 funds opening new positions, 969 increasing their positions, 880 reducing their positions, and 151 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,285
Holders Change
-76
Holders Change %
-3.22%
% of All Funds
40.13%
Holding in Top 10
64
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-11.11%
% of All Funds
1.12%
New
109
Increased
969
Reduced
880
Closed
151
Calls
$1.55B
Puts
$1.29B
Net Calls
+$265M
Net Calls Change
-$146M
Top Buyers
| 1 |
Two Sigma Advisers
New York
|
+$342M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$282M |
| 3 |
Boston Partners
Boston,
Massachusetts
|
+$246M |
| 4 |
Barclays
London,
United Kingdom
|
+$139M |
| 5 |
JPMorgan Chase & Co
New York
|
+$135M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$418M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
-$254M |
| 3 |
Berkshire Hathaway
Omaha,
Nebraska
|
-$251M |
| 4 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$182M |
| 5 |
KBC Group
Brussels,
Belgium
|
-$140M |
